Erenumab: Phase II data

Top-line data from the double-blind, international Phase II 20120295 trial in 667 patients with chronic migraine showed that

Read the full 188 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE